Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China

Table 2 Fever and ADWG from challenge day (28 DPV) to necropsy day (21 DPC)

Group	Days with fever (≥40 °C)	Body weight			ADWG before challenge	ADWG after challenge
Group	Days with fever (≥40 °C)	Day at vaccination	Day at challenge	28 DPC	ADWG before challenge	ADWG after challenge
1	0	9.54 ± 0.34	20.84 ± 0.63	35.38 ± 1.06	0.40 ± 0.01	0.69 ± 0.03
2	0	9.58 ± 0.81	20.02 ± 1.79	32.16 ± 4.03	0.37 ± 0.04	0.58 ± 0.11
3	0	6.58 ± 0.26	16.48 ± 0.95	27.18 ± 1.94	0.35 ± 0.03	0.51 ± 0.05
4	0	6.85 ± 0.38	18.15 ± 1.21	30.30 ± 1.87	0.40 ± 0.03	0.58 ± 0.03
5	0.40 ± 0.25	7.10 ± 0.50	15.40 ± 1.12	26.88 ± 2.08	0.30 ± 0.04	0.55 ± 0.05
6	0	6.55 ± 0.25	16.15 ± 1.35	31.10 ± 2.80	0.34 ± 0.04	0.61 ± 0.07

ADWG average daily weight gain, DPC days post challenge, DPV days post vaccination

ISSN: 1743-422X